CEREGENE - Company Description and OverviewCeregene's primary focus is the discovery and development of novel genetic therapeutics for the treatment of neurological disorders. Ceregene is initially focused on the treatment of Alzheimer's and Parkinson's diseases using in vivo gene delivery technology. In addition, the company will carry out pre-clinical development for additional neurodegenerative targets such as Huntington's disease and Amyotrophic Lateral Sclerosis (ALS).
- Drug Development
LEARN MORE ABOUT CEREGENE
More detailed information and downloadable data for Ceregene is available at CB Insights.